אוסטרליה - אנגלית - Department of Health (Therapeutic Goods Administration)

alembic pharmaceuticals australia pty ltd - oseltamivir phosphate, quantity: 98.528 mg - capsule, hard - excipient ingredients: purified talc; pregelatinised maize starch; povidone; sodium stearylfumarate; croscarmellose sodium; titanium dioxide; purified water; iron oxide yellow; iron oxide red; gelatin; propylene glycol; indigo carmine; ethanol; butan-1-ol; isopropyl alcohol; shellac; strong ammonia solution - oseltamivir phosphate is indicated for the treatment of infections due to influenza a and b viruses in adults and children including full-term neonates. treatment should commence as soon as possible, but no later than 48 hours after the onset of the initial symptoms of infection.,oseltamivir phosphate is indicated for the prevention of influenza in adults and children aged 1 year and older. vaccination is the preferred method of routine prophylaxis against infection with influenza virus.

אוסטרליה - אנגלית - Department of Health (Therapeutic Goods Administration)

alembic pharmaceuticals australia pty ltd - oseltamivir phosphate, quantity: 59.117 mg - capsule, hard - excipient ingredients: povidone; sodium stearylfumarate; purified talc; pregelatinised maize starch; croscarmellose sodium; titanium dioxide; purified water; gelatin; iron oxide black; propylene glycol; indigo carmine; ethanol; butan-1-ol; isopropyl alcohol; shellac; strong ammonia solution - oseltamivir phosphate is indicated for the treatment of infections due to influenza a and b viruses in adults and children including full-term neonates. treatment should commence as soon as possible, but no later than 48 hours after the onset of the initial symptoms of infection.,oseltamivir phosphate is indicated for the prevention of influenza in adults and children aged 1 year and older. vaccination is the preferred method of routine prophylaxis against infection with influenza virus.

אוסטרליה - אנגלית - Department of Health (Therapeutic Goods Administration)

alembic pharmaceuticals australia pty ltd - oseltamivir phosphate, quantity: 39.411 mg - capsule, hard - excipient ingredients: pregelatinised maize starch; purified talc; povidone; sodium stearylfumarate; croscarmellose sodium; propylene glycol; indigo carmine; ethanol; butan-1-ol; isopropyl alcohol; shellac; strong ammonia solution; titanium dioxide; purified water; iron oxide yellow; iron oxide red; gelatin - oseltamivir phosphate is indicated for the treatment of infections due to influenza a and b viruses in adults and children including full-term neonates. treatment should commence as soon as possible, but no later than 48 hours after the onset of the initial symptoms of infection.,oseltamivir phosphate is indicated for the prevention of influenza in adults and children aged 1 year and older. vaccination is the preferred method of routine prophylaxis against infection with influenza virus.

אוסטרליה - אנגלית - Department of Health (Therapeutic Goods Administration)

alembic pharmaceuticals australia pty ltd - candesartan cilexetil, quantity: 32 mg; hydrochlorothiazide, quantity: 12.5 mg - tablet, uncoated - excipient ingredients: macrogol 8000; hyprolose; iron oxide yellow; magnesium stearate; lactose monohydrate; maize starch; carmellose calcium - the treatment of hypertension. treatment should not be initiated with these fixed dose combinations.

אוסטרליה - אנגלית - Department of Health (Therapeutic Goods Administration)

alembic pharmaceuticals australia pty ltd - hydrochlorothiazide, quantity: 25 mg; candesartan cilexetil, quantity: 32 mg - tablet, uncoated - excipient ingredients: magnesium stearate; lactose monohydrate; macrogol 8000; hyprolose; maize starch; carmellose calcium; iron oxide red - the treatment of hypertension. treatment should not be initiated with these fixed dose combinations.

אוסטרליה - אנגלית - Department of Health (Therapeutic Goods Administration)

alembic pharmaceuticals australia pty ltd - hydrochlorothiazide, quantity: 12.5 mg; candesartan cilexetil, quantity: 16 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; magnesium stearate; carmellose calcium; macrogol 8000; hyprolose; maize starch; iron oxide red - the treatment of hypertension. treatment should not be initiated with these fixed dose combinations.

אוסטרליה - אנגלית - Department of Health (Therapeutic Goods Administration)

alembic pharmaceuticals australia pty ltd - candesartan cilexetil, quantity: 32 mg - tablet, uncoated - excipient ingredients: carmellose calcium; magnesium stearate; lactose monohydrate; hyprolose; macrogol 8000; maize starch; iron oxide red - treatment of hypertension.,treatment of patients with heart failure and impaired left ventricular systolic function (left ventricular ejection fraction <=40percent) as add-on therapy to ace inhibitors or when ace inhibitors are not tolerated.

אוסטרליה - אנגלית - Department of Health (Therapeutic Goods Administration)

alembic pharmaceuticals australia pty ltd - candesartan cilexetil, quantity: 16 mg - tablet, uncoated - excipient ingredients: macrogol 8000; hyprolose; lactose monohydrate; carmellose calcium; maize starch; magnesium stearate; iron oxide red - treatment of hypertension.,treatment of patients with heart failure and impaired left ventricular systolic function (left ventricular ejection fraction <=40percent) as add-on therapy to ace inhibitors or when ace inhibitors are not tolerated.

אוסטרליה - אנגלית - Department of Health (Therapeutic Goods Administration)

alembic pharmaceuticals australia pty ltd - candesartan cilexetil, quantity: 8 mg - tablet, uncoated - excipient ingredients: magnesium stearate; macrogol 8000; hyprolose; lactose monohydrate; maize starch; carmellose calcium; iron oxide red - treatment of hypertension.,treatment of patients with heart failure and impaired left ventricular systolic function (left ventricular ejection fraction <=40percent) as add-on therapy to ace inhibitors or when ace inhibitors are not tolerated.

אוסטרליה - אנגלית - Department of Health (Therapeutic Goods Administration)

alembic pharmaceuticals australia pty ltd - candesartan cilexetil, quantity: 4 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; maize starch; carmellose calcium; magnesium stearate; hyprolose; macrogol 8000; iron oxide red - treatment of hypertension.,treatment of patients with heart failure and impaired left ventricular systolic function (left ventricular ejection fraction <=40percent) as add-on therapy to ace inhibitors or when ace inhibitors are not tolerated.